Category: Healthcare
-
Date:
Homeopathic Products Market Set to Surpass USD 32.4 Billion by 2031 at 11.6% CAGR Driven by Rising Chronic Diseases, Expanding CAM Adoption, and Strategic Industry Expansions
The global homeopathic products market has demonstrated strong growth potential, supported by increasing consumer inclination toward natural and alternative healthcare solutions. The…
-
Date:
Premenstrual Syndrome Treatment Market to Reach Over USD 1.9 Bn by 2031 — By Drug Type / Distribution Channel | U.S. • Germany • China • India
The global Premenstrual Syndrome (PMS) Treatment Market was valued at US$ 1.3 billion in 2021 and is projected to surpass US$ 1.9…
-
Date:
Global Dyspareunia Treatment Market to Reach USD 1.02 Billion by 2031, Driven by Growth Strategies of Leading Players such as BASF, Dow, and Evonik
The global Dyspareunia Treatment Market was valued at USD 689.0 million in 2021 and is projected to reach USD 1.02 billion by…
-
Date:
Nanorobotics in Medicine Market Set to Reach USD 12.6 Bn by 2031, Driven by Breakthroughs in Targeted Drug Delivery and Molecular Robotics
The global nanorobotics in medicine market was valued at US$ 4.8 Bn in 2021 and is projected to reach US$ 12.6 Bn…
-
Date:
PET Radiotracer Market to Reach USD 3.2 Billion by 2031, Driven by 8.5% CAGR Growth in Advanced Diagnostic Imaging
The PET Radiotracer Market is a crucial segment within the nuclear medicine and molecular imaging industry. Positron Emission Tomography (PET) radiotracers are…
-
Date:
Gemcitabine HCL Market to Exceed US$ 1.3 Billion by 2031, Driven by Rising Cancer Prevalence and Growing Demand for Chemotherapy Treatments | TMR
Gemcitabine HCL Market Overview Gemcitabine HCL is a widely used chemotherapeutic agent and antimetabolite drug primarily utilized in the treatment of various…
-
Date:
Macular Degeneration Treatment Market to Surpass US$ 21.1 Billion by 2031 Driven by Aging Population and Advancements in Ophthalmic Therapies
The global macular degeneration treatment market is witnessing strong growth, supported by the rising prevalence of age-related eye disorders and increasing demand for advanced…
-
Date:
Ketoanalogue for Kidney Disease Market Outlook 2031: Rising CKD Burden to Drive Market to Over USD 409.6 Million at 6.5% CAGR
The global ketoanalogue for kidney disease market was valued at US$ 214.7 Mn in 2021 and is projected to expand at a…
-
Date:
Gout Therapeutics Market to be Worth Over USD 4.9 Bn by 2031 — Driven by Rising Gout Prevalence, Aging Population, and Advancements in Treatment Therapies
The global gout therapeutics market was valued at US$ 2.2 billion in 2021 and is projected to exceed US$ 4.9 billion by…
-
![Chronic Kidney Disease [CKD] Nutritional Supplement Market](https://www.keepfacts.com/wp-content/uploads/2026/04/ChatGPT-Image-Apr-24-2026-05_13_16-PM.png)
Date:
Chronic Kidney Disease Nutritional Supplement Market to Exceed USD 5.0 Billion by 2031 | Abbott, Fresenius Kabi, and Nestlé Health Science Lead Growth
The global chronic kidney disease nutritional supplement market was valued at US$ 3.3 billion in 2021 and is projected to grow at…
Olivia
Carter
is a writer covering health, tech, lifestyle, and economic trends. She loves crafting engaging stories that inform and inspire readers.
